ProCE Banner Activity

幻灯片:影响我在 CROI 2022 之后行医的关键 HIV 研究

Slideset Download

回顾专家教员对 IDWeek 和 HIV Glasgow 2022 的关键 HIV 研究的总结,包括预防策略、长效疗法、日常口服疗法、研究性药物以及 HIV 和 COVID-19 的研究结果。

Released: December 16, 2022

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, Viiv Healthcare.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharp & Dohme, ViiV.